TGFβ Signaling in the Pancreatic Tumor Microenvironment
Pancreatic ductal adenocarcinoma (PDAC) is associated with poor clinical outcomes, largely attributed to incomplete responses to standard therapeutic approaches. Recently, selective inhibitors of the Transforming Growth Factor β (TGFβ) signaling pathway have shown early promise in the treatment of P...
Main Authors: | Daniel R. Principe, Kaytlin E. Timbers, Luke G. Atia, Regina M. Koch, Ajay Rana |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/20/5086 |
Similar Items
-
TGF-β Signaling: From Tissue Fibrosis to Tumor Microenvironment
by: Jeff Yat-Fai Chung, et al.
Published: (2021-07-01) -
TGF-β in Cancer: Metabolic Driver of the Tolerogenic Crosstalk in the Tumor Microenvironment
by: Roberta Angioni, et al.
Published: (2021-01-01) -
TGF-β signaling in the tumor metabolic microenvironment and targeted therapies
by: Xueke Shi, et al.
Published: (2022-09-01) -
TGFβ and the Tumor Microenvironment in Colorectal Cancer
by: Maximilian J. Waldner, et al.
Published: (2023-04-01) -
The role of TGF-β in the tumor microenvironment of pancreatic cancer
by: Qiang Luo, et al.
Published: (2023-07-01)